TY - JOUR T1 - EBUS TBNA with Fast Trak. A cost effective and efficient alternative to ROSE – Is there really a need for ROSE? JF - European Respiratory Journal JO - Eur Respir J VL - 44 IS - Suppl 58 SP - P3549 AU - Amir M. Khan AU - Filiz Oezkan AU - Dirk Theegarten AU - Lutz Freitag AU - Kaid Darwiche Y1 - 2014/09/01 UR - http://erj.ersjournals.com/content/44/Suppl_58/P3549.abstract N2 - Intro: Rapid on site cytology- ROSE with EBUS TBNA is thought to increase diagnostic yield eliminate the need for additional bronchoscopic procedures in initial diagnosis of lung cancer. Recently the importance of ROSE & its associated increase costs has been questioned. Currently there are limited reported alternatives to ROSE.Aims/Objective:The aim of our study is to assess our FAST TRAK times, & to see if it is a suitable alternative to ROSE.Methods & Material: A retrospective review of 105 consecutive cases of CP-EBUS TBNA with recorded FAST TRAK times. All patients underwent rigid intubation, jet ventilation & IV GA with muscle relaxants.Samples were taken to the cytologist to have an initial verbal report, followed by a written report. Age & gender, FAST TRAK times, Avg total no. of lymph nodes biopsied, & final diagnosis & complications were recorded for all patients.Results: Of the total 105 cases of EBUS TBNA, 92 patients were identified with FAST TRAK times. 12 patients had missing data. Of the 80 patients identified there were 54 men & 26 women with an Avg age of 68.6 years. The avg. total FAST TRAK time was 24mts:37 secs. Avg total no. of lymph node biopsied were 3.3. The overall disease prevalence was 56.2% (45 positive cases, 31 NSCLC, 11 SCLC, 1 case each of lymphoma, sarcoma, & sarcoidosis). The overall FAST TRAK reported specificity was 97.1%, sensitivity was 93.3%, PPV 97.6% & NPV 91.8%. No complications were recorded.Conclusion: We conclude that reliable & fast results can be obtained with FAST TRAK with EBUS TBNA. FAST TRAK maybe a cost effective & efficient alternative to ROSE & may play an important role in diagnosis & treatment of lung cancer. ER -